APVO logo

Aptevo Therapeutics (APVO) Cash From Operations

Annual CFO

-$11.73 M
+$9.29 M+44.20%

December 31, 2023

Summary

Performance

1-Year Change

+44.2%

3-Year Change

+59.99%

5-Year Change

+77.19%

15-Year Change

+71.78%

APVO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.47%
APVO annual cash flow from operations is higher than 57.47% of companies in Healthcare sector

High & Low

All-time High

-$11.73 M
APVO annual cash flow from operations is currently at an all-time high

3-Year Low

-$21.68 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
APVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
APVO next annual earnings announcement is scheduled for Mar 5, 2025

OtherAPVOcash flowmetrics:

Annual CFI

$0.00
APVO annual cash flow from investing activities is $0.00

Annual CFF

$6.00 M
APVO annual cash flow from financing activities is $6.00 million

Annual FCF

-$11.73 M
APVO annual free cash flow is -$11.73 million

Annual CAPEX

-
APVO annual capital expenditures value is unknown

Quarterly CFO

-$5.22 M
+$931.00 K+15.13%

September 30, 2024

Summary

Performance

3-Month Change

+15.13%

1-Year Change

+0.59%

3-Year Change

+0.59%

5-Year Change

-2.39%

APVO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.37%
APVO quarterly cash flow from operations is higher than 44.37% of companies in Healthcare sector

High & Low

All-time High

$4.57 M
APVO quarterly cash flow from operations is currently -214.37% below its historical high of $4.57 million

3-Year Low

-$6.90 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
APVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
APVO next earnings announcement is scheduled for Mar 5, 2025

OtherAPVOcash flowmetrics:

Quarterly CFI

$0.00
APVO quarterly cash flow from investing activities is $0.00

Quarterly CFF

$4.91 M
APVO quarterly cash flow from financing activities is $4.91 million

Quarterly FCF

-$5.22 M
APVO quarterly free cash flow is -$5.22 million

Quarterly CAPEX

-
APVO quarterly capital expenditures value is unknown

TTM CFO

-$23.28 M
+$1.02 M+4.19%

September 30, 2024

Summary

Performance

3-Month Change

+4.19%

1-Year Change

-98.46%

3-Year Change

-98.46%

5-Year Change

+45.07%

APVO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.1%
APVO TTM cash flow from operations is higher than 42.1% of companies in Healthcare sector

High & Low

All-time High

-$11.34 M

3-Year Low

-$24.30 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
APVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
APVO next earnings announcement is scheduled for Mar 5, 2025

OtherAPVOcash flowmetrics:

TTM CFI

$0.00
APVO TTM cash flow from investing activities is $0.00

TTM CFF

$11.92 M
APVO TTM cash flow from financing activities is $11.92 million

TTM FCF

-$23.28 M
APVO TTM free cash flow is -$23.28 million

TTM CAPEX

-
APVO TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

APVO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.2%+0.6%-98.5%
3 y3 years+60.0%+0.6%-98.5%
5 y5 years+77.2%-2.4%+45.1%

APVO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+45.9%-214.4%+24.3%-105.3%+4.2%
5 y5-yearat high+72.3%-214.4%+53.3%-105.3%+45.1%
alltimeall timeat high+77.2%-214.4%+69.2%-105.3%+60.9%

Aptevo Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.22 M(-15.1%)
-$23.28 M(-4.2%)
Jun 2024
-
-$6.15 M(-7.5%)
-$24.30 M(+5.9%)
Mar 2024
-
-$6.65 M(+26.6%)
-$22.95 M(+95.6%)
Dec 2023
-$11.73 M(-44.2%)
-$5.25 M(-15.8%)
-$11.73 M(-5.5%)
Sep 2023
-
-$6.24 M(+29.9%)
-$12.42 M(-5.0%)
Jun 2023
-
-$4.80 M(-205.2%)
-$13.07 M(+15.3%)
Mar 2023
-
$4.57 M(-176.9%)
-$11.34 M(-46.1%)
Dec 2022
-$21.02 M(-3.0%)
-$5.94 M(-13.9%)
-$21.02 M(+10.9%)
Sep 2022
-
-$6.90 M(+124.6%)
-$18.96 M(+9.6%)
Jun 2022
-
-$3.07 M(-40.0%)
-$17.31 M(-10.3%)
Mar 2022
-
-$5.12 M(+31.9%)
-$19.29 M(-11.0%)
Dec 2021
-$21.68 M(-26.1%)
-$3.88 M(-26.0%)
-$21.68 M(-9.4%)
Sep 2021
-
-$5.24 M(+3.7%)
-$23.92 M(-8.2%)
Jun 2021
-
-$5.05 M(-32.7%)
-$26.07 M(+1.6%)
Mar 2021
-
-$7.50 M(+22.6%)
-$25.65 M(-12.5%)
Dec 2020
-$29.32 M(-30.8%)
-$6.12 M(-17.1%)
-$29.32 M(+3.6%)
Sep 2020
-
-$7.39 M(+59.4%)
-$28.30 M(-0.6%)
Jun 2020
-
-$4.63 M(-58.5%)
-$28.46 M(-28.3%)
Mar 2020
-
-$11.18 M(+119.1%)
-$39.71 M(-6.3%)
Dec 2019
-$42.38 M
-$5.10 M(-32.4%)
-$42.38 M(-4.9%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$7.55 M(-52.5%)
-$44.58 M(-7.5%)
Jun 2019
-
-$15.89 M(+14.8%)
-$48.17 M(-0.2%)
Mar 2019
-
-$13.84 M(+89.9%)
-$48.29 M(-6.1%)
Dec 2018
-$51.42 M(+23.7%)
-$7.29 M(-34.6%)
-$51.42 M(-13.7%)
Sep 2018
-
-$11.15 M(-30.4%)
-$59.55 M(+19.1%)
Jun 2018
-
-$16.01 M(-5.7%)
-$50.02 M(+7.5%)
Mar 2018
-
-$16.98 M(+10.1%)
-$46.52 M(+11.9%)
Dec 2017
-$41.57 M(+12.8%)
-$15.42 M(+854.3%)
-$41.57 M(+26.7%)
Sep 2017
-
-$1.62 M(-87.1%)
-$32.82 M(+4.7%)
Jun 2017
-
-$12.51 M(+4.0%)
-$31.34 M(-9.9%)
Mar 2017
-
-$12.03 M(+80.5%)
-$34.78 M(-5.7%)
Dec 2016
-$36.86 M(-24.4%)
-$6.67 M(+4873.9%)
-$36.86 M(-2.7%)
Sep 2016
-
-$134.00 K(-99.2%)
-$37.88 M(-19.6%)
Jun 2016
-
-$15.95 M(+13.0%)
-$47.10 M(+0.3%)
Mar 2016
-
-$14.11 M(+83.7%)
-$46.95 M(-3.7%)
Dec 2015
-$48.76 M(+3.7%)
-$7.68 M(-17.9%)
-$48.76 M(+18.7%)
Sep 2015
-
-$9.36 M(-40.8%)
-$41.08 M(+29.5%)
Jun 2015
-
-$15.80 M(-0.7%)
-$31.72 M(+99.3%)
Mar 2015
-
-$15.92 M
-$15.92 M
Dec 2014
-$47.01 M(-8.5%)
-
-
Dec 2013
-$51.39 M
-
-

FAQ

  • What is Aptevo Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Aptevo Therapeutics?
  • What is Aptevo Therapeutics annual CFO year-on-year change?
  • What is Aptevo Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Aptevo Therapeutics?
  • What is Aptevo Therapeutics quarterly CFO year-on-year change?
  • What is Aptevo Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Aptevo Therapeutics?
  • What is Aptevo Therapeutics TTM CFO year-on-year change?

What is Aptevo Therapeutics annual cash flow from operations?

The current annual CFO of APVO is -$11.73 M

What is the all time high annual CFO for Aptevo Therapeutics?

Aptevo Therapeutics all-time high annual cash flow from operations is -$11.73 M

What is Aptevo Therapeutics annual CFO year-on-year change?

Over the past year, APVO annual cash flow from operations has changed by +$9.29 M (+44.20%)

What is Aptevo Therapeutics quarterly cash flow from operations?

The current quarterly CFO of APVO is -$5.22 M

What is the all time high quarterly CFO for Aptevo Therapeutics?

Aptevo Therapeutics all-time high quarterly cash flow from operations is $4.57 M

What is Aptevo Therapeutics quarterly CFO year-on-year change?

Over the past year, APVO quarterly cash flow from operations has changed by +$31.00 K (+0.59%)

What is Aptevo Therapeutics TTM cash flow from operations?

The current TTM CFO of APVO is -$23.28 M

What is the all time high TTM CFO for Aptevo Therapeutics?

Aptevo Therapeutics all-time high TTM cash flow from operations is -$11.34 M

What is Aptevo Therapeutics TTM CFO year-on-year change?

Over the past year, APVO TTM cash flow from operations has changed by -$11.55 M (-98.46%)